These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relationship between FEV Kemp R; Pustulka I; Boerner G; Smela B; Hofstetter E; Sabeva Y; François C Respir Med; 2021 Nov; 188():106608. PubMed ID: 34517199 [TBL] [Abstract][Full Text] [Related]
23. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700 [TBL] [Abstract][Full Text] [Related]
25. Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Huang QS; Han TX; Chen Q; Wu J; Zhao P; Wu YJ; He Y; Zhu XL; Fu HX; Wang FR; Zhang YY; Mo XD; Han W; Yan CH; Wang JZ; Chen H; Chen YH; Han TT; Lv M; Chen Y; Wang Y; Xu LP; Liu KY; Huang XJ; Zhang XH Bone Marrow Transplant; 2024 Feb; 59(2):239-246. PubMed ID: 38012449 [TBL] [Abstract][Full Text] [Related]
29. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation. Yoon JS; Chun YH; Lee JW; Chung NG; Cho B J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431 [TBL] [Abstract][Full Text] [Related]
30. What are the best pulmonary function test parameters for early detection of post-lung transplant bronchiolitis obliterans syndrome in children? Sritippayawan S; Keens TG; Horn MV; Starnes VA; Woo MS Pediatr Transplant; 2003 Jun; 7(3):200-3. PubMed ID: 12756044 [TBL] [Abstract][Full Text] [Related]
31. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542 [TBL] [Abstract][Full Text] [Related]
39. The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study. Chen S; Zhao K; Lin R; Wang S; Fan Z; Huang F; Chen X; Nie D; Du X; Guo Z; Lin D; Xuan L; Xu N; Sun J; Peng Xiang A; Liu Q EBioMedicine; 2019 Nov; 49():213-222. PubMed ID: 31668569 [TBL] [Abstract][Full Text] [Related]
40. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE; Cowen EW; Justus DG; Baird K; Cheng GS; Avila D; Steinberg SM; Mitchell SA; Gress RE Transplant Cell Ther; 2022 May; 28(5):264.e1-264.e9. PubMed ID: 35114411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]